26
Participants
Start Date
November 5, 2009
Primary Completion Date
February 25, 2010
Study Completion Date
February 25, 2010
Paroxetine CR and Paroxetine IR
Randomized, 2-period crossover repeat dosing of Paroxetine CR at 25 mg/day for 14 days and Paroxetine IR at 20 mg/day for 14 days in Japanese healthy male volunteers
GSK Investigational Site, Tokyo
Lead Sponsor
GlaxoSmithKline
INDUSTRY